Journal article · 2026 · Open access

Development and evaluation of nanoliposomal drug delivery system for enhanced solubility and controlled release of poorly soluble drugs

Shashank Tiwari

International Journal of Pharmaceutical Research and Development, 8(7), 110–121 · Published 1 July 2026 · DOI 10.33545/26646862.2026.v8.i7a.403

Free PDFView at the publisherCite this paper

In brief

“Development and evaluation of nanoliposomal drug delivery system for enhanced solubility and controlled release of poorly soluble drugs” is a 2026 journal article by Shashank Tiwari, published in International Journal of Pharmaceutical Research and Development. OpenAlex counts 0 citations as of 15 November 2026. It is open access: the full text is free to read at International Journal of Pharmaceutical Research and Development.

Citations
0
Authors
1

Abstract

One of the major challenges in the pharmaceutical development is the poor aqueous solubility which affects the dissolution of the newly discovered drug molecules, their bioavailability and therapeutic efficacy. In most formulation approaches these drawbacks are not overcome and new drug delivery systems are required. Nanoliposomal drug delivery systems (NDDS) have been considered as a promising nanocarrier system because of their good biocompatibility, biodegradability, and capability to encapsulate both hydrophobic and hydrophilic drugs. The nanoliposomes can increase the apparent aqueous solubility of poorly soluble drugs, stabilize the drug, increase the bioavailability and give a controlled and sustained release of the drug by incorporating it within the phospholipid bilayer. The current review aims to give an overview on the development and assessment of nanoliposomal drug delivery systems designed for poorly soluble drugs. It addresses the structure of nanoliposomes, choice of lipids and excipients, and some of the more popular methods of preparation, such as thin-film hydration, ethanol injection, and reverse-phase evaporation. Moreover, the review emphasizes on the important characterization parameters such as particle size, polydispersity index (PDI), zeta potential, entrapment efficiency (EE), morphological evaluation, in vitro drug release, and stability studies. Some recent pharmaceutical applications of enhanced solubility, extended drug release and better therapeutic activity are also discussed. Furthermore, current formulation challenges including formulation stability, large scale manufacturing, regulatory and commercialization requirements are presented as well as emerging trends including targeted liposomes, stimuli responsive formulations, microfluidic manufacturing and artificial intelligence formulation design. Overall, the nanoliposomal drug delivery system is a versatile and effective platform that can enhance the pharmaceutical properties of poorly soluble drugs. As formulations technologies and manufacturing strategies continue to improve, their translation into clinical applications and expansion into various therapeutic areas should continue to grow at a rapid pace.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Tiwari, S. (2026). Development and evaluation of nanoliposomal drug delivery system for enhanced solubility and controlled release of poorly soluble drugs. International Journal of Pharmaceutical Research and Development, 8(7), 110–121. https://doi.org/10.33545/26646862.2026.v8.i7a.403

MLA 9

Tiwari, Shashank. “Development and evaluation of nanoliposomal drug delivery system for enhanced solubility and controlled release of poorly soluble drugs.” International Journal of Pharmaceutical Research and Development, vol. 8, no. 7, 2026, pp. 110–121. https://doi.org/10.33545/26646862.2026.v8.i7a.403.

Chicago

Tiwari, Shashank. 2026. “Development and evaluation of nanoliposomal drug delivery system for enhanced solubility and controlled release of poorly soluble drugs.” International Journal of Pharmaceutical Research and Development 8 (7): 110–121. https://doi.org/10.33545/26646862.2026.v8.i7a.403.

Harvard

Tiwari, S. (2026) ‘Development and evaluation of nanoliposomal drug delivery system for enhanced solubility and controlled release of poorly soluble drugs’, International Journal of Pharmaceutical Research and Development, 8(7), pp. 110–121. doi:10.33545/26646862.2026.v8.i7a.403.

IEEE

S. Tiwari, “Development and evaluation of nanoliposomal drug delivery system for enhanced solubility and controlled release of poorly soluble drugs,” International Journal of Pharmaceutical Research and Development, vol. 8, no. 7, pp. 110–121, 2026, doi: 10.33545/26646862.2026.v8.i7a.403.

BibTeX

@article{tiwari2026development,
  title     = {{Development and evaluation of nanoliposomal drug delivery system for enhanced solubility and controlled release of poorly soluble drugs}},
  author    = {Tiwari, Shashank},
  journal   = {International Journal of Pharmaceutical Research and Development},
  year      = {2026},
  volume    = {8},
  number    = {7},
  pages     = {110--121},
  doi       = {10.33545/26646862.2026.v8.i7a.403},
  url       = {https://doi.org/10.33545/26646862.2026.v8.i7a.403}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • nanoliposomes
  • poorly water-soluble drugs
  • drug solubility enhancement
  • controlled drug release
  • sustained drug release
  • liposome preparation
  • thin-film hydration
  • ethanol injection

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Tiwari, S. (2026). Development and evaluation of nanoliposomal drug delivery system for enhanced solubility and controlled release of poorly soluble drugs. International Journal of Pharmaceutical Research and Development, 8(7), 110–121. https://doi.org/10.33545/26646862.2026.v8.i7a.403

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at International Journal of Pharmaceutical Research and Development.

Who wrote this paper?

Shashank Tiwari.

What is the DOI of this paper?

10.33545/26646862.2026.v8.i7a.403. The permanent link is https://doi.org/10.33545/26646862.2026.v8.i7a.403.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.